1. Home
  2. SGHT vs PMM Comparison

SGHT vs PMM Comparison

Compare SGHT & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • PMM
  • Stock Information
  • Founded
  • SGHT 2011
  • PMM 1989
  • Country
  • SGHT United States
  • PMM United States
  • Employees
  • SGHT N/A
  • PMM N/A
  • Industry
  • SGHT Medical Specialities
  • PMM Investment Managers
  • Sector
  • SGHT Health Care
  • PMM Finance
  • Exchange
  • SGHT Nasdaq
  • PMM Nasdaq
  • Market Cap
  • SGHT 304.4M
  • PMM 296.6M
  • IPO Year
  • SGHT 2021
  • PMM N/A
  • Fundamental
  • Price
  • SGHT $3.58
  • PMM $6.28
  • Analyst Decision
  • SGHT Buy
  • PMM
  • Analyst Count
  • SGHT 7
  • PMM 0
  • Target Price
  • SGHT $6.27
  • PMM N/A
  • AVG Volume (30 Days)
  • SGHT 217.8K
  • PMM 118.3K
  • Earning Date
  • SGHT 11-07-2024
  • PMM 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • PMM 4.68%
  • EPS Growth
  • SGHT N/A
  • PMM N/A
  • EPS
  • SGHT N/A
  • PMM 0.23
  • Revenue
  • SGHT $79,543,000.00
  • PMM N/A
  • Revenue This Year
  • SGHT $2.18
  • PMM N/A
  • Revenue Next Year
  • SGHT $8.14
  • PMM N/A
  • P/E Ratio
  • SGHT N/A
  • PMM $26.52
  • Revenue Growth
  • SGHT N/A
  • PMM N/A
  • 52 Week Low
  • SGHT $3.12
  • PMM $5.00
  • 52 Week High
  • SGHT $8.45
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 33.92
  • PMM 46.47
  • Support Level
  • SGHT $3.65
  • PMM $6.30
  • Resistance Level
  • SGHT $4.04
  • PMM $6.43
  • Average True Range (ATR)
  • SGHT 0.21
  • PMM 0.07
  • MACD
  • SGHT 0.04
  • PMM 0.00
  • Stochastic Oscillator
  • SGHT 2.25
  • PMM 30.77

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: